文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

前列腺外照射联合高剂量率近距离放疗:形变配准计划的剂量体积参数与晚期胃肠道并发症相关

Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complications.
PubMed 文献 · Radiat Oncol · 2016-10-31

BACKGROUND: Derivation of dose-volume correlated with toxicity for multi-modal treatments can be difficult due to the perceived need for voxel-by-voxel dose accumulation.…

要点

  • 形变配准结合EBRT/HDR各阶段后,直肠剂量体积参数与晚期胃肠道毒性显著相关。
  • 分布叠加法中48-80 Gy、40-63 Gy、49-55 Gy分别与直肠出血、里急后重/便急、排便频率相关。

核心结论

  • 形变配准联合EBRT/HDR前列腺癌治疗各阶段后,证实胃肠道毒性存在显著的剂量直方图效应。
  • 中高剂量区和接近最大剂量对直肠出血重要,分布叠加法的中高剂量区对排便频率和里急后重/便急也重要。

研究设计与样本

  • HDR CT形变配准至EBRT CT,剂量经分次校正,直肠DVH参数用分布叠加和参数叠加两种方法计算。
  • 采用逻辑回归和Mann-Whitney U检验分析参数与晚期峰值毒性(二分类为1级或2级)的相关性。

主要发现

  • 分布叠加法中48-80 Gy剂量区与直肠出血显著相关,40-63 Gy与里急后重/便急显著相关,49-55 Gy与排便频率显著相关。
  • 分布叠加法中25-26 Gy与里急后重/便急相关,44-48 Gy与肛门直肠疼痛相关。
  • 参数叠加法显示低-中剂量区与排便频率和直肠炎显著相关。
  • 分布叠加法结果在多数情况下与参数叠加法一致。

临床怎么用

  • 对于接受EBRT联合HDR近距离放疗的前列腺癌患者,可考虑使用形变配准叠加剂量评估直肠剂量体积参数以预测晚期胃肠道毒性。
  • 关注直肠中高剂量区和接近最大剂量,以降低直肠出血风险。

局限性

  • 研究鼓励使用适当的分次间运动管理开展进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Derivation of dose-volume correlated with toxicity for multi-modal treatments can be difficult due to the perceived need for voxel-by-voxel dose accumulation. With data available for a single-institution cohort with long follow-up, an investigation was undertaken into rectal dose-volume effects for gastrointestinal toxicities after deformably-registering each phase of a combined external beam radiotherapy (EBRT)/high-dose-rate (HDR) brachytherapy prostate treatment. METHODS: One hundred and eighteen patients received EBRT in 23 fractions of 2 Gy and HDR (TG43 algorithm) in 3 fractions of 6.5 Gy. Results for the Late Effects of Normal Tissues - Subjective, Objective, Management and Analytic toxicity assessments were available with a median follow-up of 72 months. The HDR CT was deformably-registered to the EBRT CT. Doses were corrected for dose fractionation. Rectum dose-volume histogram (DVH) parameters were calculated in two ways. (1) Distribution-adding: parameters were calculated after the EBRT dose distribution was 3D-summed with the registered HDR dose distribution. (2) Parameter-adding: the EBRT DVH parameters were added to HDR DVH parameters. Logistic regressions and Mann-Whitney U-tests were used to correlate parameters with late peak toxicity (dichotomised at grade 1 or 2). RESULTS: The 48-80, 40-63 and 49-55 Gy dose regions from distribution-adding were significantly correlated with rectal bleeding, urgency/tenesmus and stool frequency respectively. Additionally, urgency/tenesmus and anorectal pain were associated with the 25-26 Gy and 44-48 Gy dose regions from distribution-adding respectively. Parameter-adding also indicated the low-mid dose region was significantly correlated with stool frequency and proctitis. CONCLUSIONS: This study confirms significant dose-histogram effects for gastrointestinal toxicities after including deformable registration to combine phases of EBRT/HDR prostate cancer treatment. The findings from distribution-adding were in most cases consistent with those from parameter-adding. The mid-high dose range and near maximum doses were important for rectal bleeding. The distribution-adding mid-high dose range was also important for stool frequency and urgency/tenesmus. We encourage additional studies in a variety of institutions using a variety of dose accumulation methods with appropriate inter-fraction motion management. TRIAL REGISTRATION: NCT NCT00193856 . Retrospectively registered 12 September 2005.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Moulton CR, House MJ, Lye V, et al. Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complications. Radiat Oncol. 2016. PMID: 27799048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。